TY - BOOK ID - 113594645 TI - Ocular Surface Infection and Antimicrobials AU - Willcox, Mark AU - Stapleton, Fiona AU - Dutta, Debarun PY - 2022 SN - 3036560599 3036560602 PB - Basel MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Bacteriology (non-medical) KW - coagulase-negative staphylococci KW - eye infections KW - endophthalmitis KW - keratitis KW - conjunctivitis KW - blepharitis KW - API Staph KW - Biolog KW - DNA sequencing KW - sodA gene KW - antibiotic susceptibility KW - bacterial infection KW - Serratia marcescens KW - transcription factor KW - ocular surface KW - epithelium KW - cornea KW - metabolomics KW - ocular infection KW - predatory bacteria KW - Bdellovibrio KW - Micavibrio KW - Pseudomonas aeruginosa KW - Enterobacterales KW - infection KW - bacteria KW - stress response system KW - antibiotic KW - Staphylococcus aureus KW - antibiotic resistance KW - biofilms KW - antimicrobial peptides KW - ciprofloxacin KW - combined effect KW - microbial keratitis KW - corneal infiltrative events KW - MPDS susceptibility KW - Staphyloccus aureus KW - MSSA KW - pulsed-field gel electrophoresis KW - multilocus sequence typing KW - Panton-Valentine leukocidin KW - Mel4 peptide KW - antimicrobial contact lens KW - extended wear KW - biocompatibility KW - comfort KW - clinical trail KW - misuse of antibiotics KW - orthokeratology KW - contact lens KW - questionnaire KW - contact lenses KW - ultraviolet C KW - Pseudomonas KW - Staphylococcus KW - Fusarium KW - Candida KW - ocular infectious isolates KW - whole genome sequencing KW - virulence factors KW - n/a UR - https://www.unicat.be/uniCat?func=search&query=sysid:113594645 AB - This reprint collates papers from a Special Issue of the journal Antibiotics, which was entitled "Ocular surface Infection and Antimicrobials". The papers cover aspects such as common microbes which cause ocular infections and their susceptibility to antibiotics; how guidelines for antibiotic use can translate to improved patient compliance; how bacteria respond to antibiotics; and lastly, new treatments and ways of preventing ocular surface infections. ER -